[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Kromek Group Plc LSE:KMK London Ordinary Share GB00BD7V5D43 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -0.62% 16.025 15.80 16.25 16.125 15.825 16.13 151,674 10:23:18
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 10.4 -6.3 -1.5 - 69

Kromek Share Discussion Threads

Showing 5276 to 5297 of 5500 messages
Chat Pages: 220  219  218  217  216  215  214  213  212  211  210  209  Older
DateSubjectAuthorDiscuss
11/9/2021
09:21
It seems to me that the detectors are going to have to be a kind of “made to measure” unit depending on where it would be located due to “appropriate use-case models appropriate for the particular location”. No accreditation as yet. No orders yet received for these detectors. Hmmmm……………
b00mb0y
11/9/2021
08:01
“Late reported Buys of 837,809 at 17.75p & 200k at 17.685p shows confidence!” I never understand comments like thus. Every purchase is also a sale. Every sale a purchase.
paulbutcher1999
10/9/2021
17:35
Late reported Buys of 837,809 at 17.75p & 200k at 17.685p shows confidence!
davethechef
10/9/2021
10:27
Fair enough AC, I just asked Paul if it okay to copy and he requested I summarise hence my format. Good questions and answers though. I agree and it should be more of a media story. One to tuck away and await the formal test results and news on commercialisation imo.
nick2412
10/9/2021
09:44
Given all seems on seems on track in terms of progress and timescale I’d say yesterday’s sell off was a little over done. I’m just a bit bewildered why Kromek aren’t engaging with the media more.
aqc888
10/9/2021
09:38
Morning Andrew Thank you for your questions and apologies for the slight delay in getting back to you. In answer to your questions: How did the biological pathogen detector do in the publicised trials? We have conducted a range of trials and pilots in locations with differing footfall densities and we are now working with those organisations to build and develop appropriate use-case models appropriate for the particular location. The trials went very well and the locations are now evaluating those use-case scenarios and how they might utilise the technology depending on the concentration of Covid or other pathogens present and identified by the technology. Has the detector been accredited yet by an independent laboratory? The technology has been evaluated by an independent laboratory which determined that it has efficacy equivalent to PCR test standards. However, there is presently no official accreditation standard for measuring airborne pathogen detection so it has not been officially “accredited221;. For information, the equipment will be CE marked when manufactured. Have any orders been received yet for the detector? We will update the market with commercial progress at the appropriate time. I hope this helps and thanks for your continued support as a shareholder. Best regards Paul
aqc888
10/9/2021
09:37
Some more responses to questions from the AGM I just received from the CFO. As questions and answers at an AGM are usually public, I don’t deem the email exchange as private.
aqc888
09/9/2021
21:01
Good points Mick, Santa will be here early this year, there`ll be fireworks too
wilsonlough
09/9/2021
14:19
ARK87, I can see you're a hard man to impress, Kromek a small UK company have developed and built the first Patho Airborne detection prototype and have them in testing off the drawing board (well CAD screen) in January this year....months.. There are to my knowledge a number of US and global companies many times the size and resources of Kromek who have tried and failed to crack this much needed design detection solution...it's an all UK tech world's first if you Weren't aware. The core RNA sequencing tech being used here was deemed almost impossible only a few years ago, 5 years latter £200 mil spent in development and today they're in the news again one of the UK's true success stories. My first old engineering boss's favourite saying was - 'The Impossible We Can Do at Once, Miracles Take a Little Longer' He worked on the design of Concorde and knew his stuff. Kromek are just about to showcase the system at a London Defence exhibition next week not bad going in my book.
33mick
09/9/2021
14:04
Ark87, they are still within the timeframe reported in the IC it’s easy to forget with all the impatience by myself and others on here. The article 2months ago said expect news in the coming months. Also the article was reporting on the covid detector which as responses to Nicks emails from the CFO seem to suggest that’s still on track. Who knows what’s going on with it... hopefully we get a bit of news next week at the dsei exhibition. If it gets a little media attention we could see another sugar rush spiral upwards while we await the trial results. A small release of new news or regurgitated old news could see that.
aqc888
09/9/2021
12:56
AQC888 - The length of time Covid detector is taking makes me believe they are surely have issues with it? It probably works but maybe not well enough to make it worthwhile hence endless amounts of tweaking? Why else could this be taking so long when under big pressure to get it out?
ark87
09/9/2021
11:15
Someone talking....
dexter1612
09/9/2021
11:11
I note there was no shareholder revolt at the AGM. Turnover was 35pc ish which is quite high given the current KMK shareholder base. I could not find the link to the notice and assume that resolution 1 which attracted a 10pc no vote was the approval of the accounts.
cerrito
09/9/2021
10:49
14th September is the before mentioned exhibition at excel. Where the theme of the show is relevant to the detector. I wouldn’t want to sell out now with details that could be released then. Remember there will be buyers of the machine there - if they have any details it would be a good time to release them.
aqc888
09/9/2021
10:41
Could well do, strategicinvestor. Its the same old, same old. Promises, promises.
b00mb0y
09/9/2021
10:33
Could drift back to 15p due to impatience for news later that financial year ?? Thought ?
strategicinvestor2
09/9/2021
10:15
Hopefully you can see this. Your a tit. I'll filter you now.
dexter1612
09/9/2021
09:30
Come on, rampers. This stock is teetering on the cliffs. I’ve got big steaks in this. Do your job and get this share price going north.
b00mb0y
09/9/2021
08:17
@dixter Are you gambling on the coulds?' It's the stock market, that's what you do. Yeah, your right, you were better when filtered. So you unfiltered me. You obviously find me interesting then. Haha. If not, then just filter me again. Bye.
b00mb0y
09/9/2021
07:58
Quepassa, so what’s your interest in Kromek? I’m guessing you’ve lost a chunk of money in Kromek from the early days and a little bit bitter about it all?
aqc888
09/9/2021
07:08
oh I do apologise if you feel my posts are lacking substance. I hope this one of mine from earlier this year on 6th April 2021 (post 4244) helps rectify the situation. Perhaps you weren't on the board at the time or missed it. "Using figures from Equity Development (7/10/20), this is Kromek's seven year performance. Rounded by me to nearest half-million. 1. TURNOVER FIGURES. 2014 £6m 2015 £8m 2016 £8.5m 2017 £9m 2018 £12m 2019 £14.5m 2020 £13m These TURNOVER figures include PRODUCT and OTHER. I assume (but am not certain) that OTHER includes/means grants and research funding. For example, in 2016 OTHER was £3m. In 2019 OTHER was £2.5m TURNOVER total for last 7 years is £71 million. 2. PROFIT BEFORE TAX - ADJUSTED 2014 -£4.5m LOSS 2015 -£3m LOSS 2016 -£4m LOSS 2017 -£4m LOSS 2018 -£2.5m LOSS 2019 -£1.5m LOSS 2020 -£4m LOSS LOSS BEFORE TAX (ADJUSTED) for last seven years is £23.5 million. 3. EQUITY RAISING SINCE IPO 30/7/15 £11million 25/1/17 £21million 12/2/19 £21million 12/2/21 £13million They had raised £53m by end 2020. And the new 2021 Placing, brings total to £66m. A great deal of shareholder dilution. 4. SUMMARY. SEVEN YEARS TURNOVER £71m LOSS £23.5m EQUITY RAISINGS £53m (+ another £13m in 2021) Where does so much money go? With so many positive messages and so many sure-fire guaranteed, copper-bottomed, game-changer, cutting-edge, state-of-the-art and innovative whizzbang new product initiatives, mostly announced to piggy-back off the latest global scare (nuclear detection, airport security, medical imaging, ventilators ,covid), why does this company still make such resolute losses? The Easter weekend marked the 7th. anniversary of the infamous 4/4/14 RNS announcement of the seven year up to $159million CZT-based detection modules contract in China. You see, if you add together ALL Kromek's TURNOVER for the last seven years, the whole lot doesn't come anywhere close to what that ONE SINGLE CONTRACT was meant to bring in. ALL IMO. DYOR. QP " ALL IMO. DYOR. QP
quepassa
09/9/2021
06:53
Need to remember that in China, Australia etc they are still closing down areas when a covid case is identified. Big market. Very different approach to U.K. we should remember U.K. is taking an approach which is very different to a lot of other countries. Also we need to remember that variants seem to be evading the vaccines and that should a new worse variant pop up the machine will be of huge importance. There will also be niche areas where there detector would be very useful. When a niche area is identified and sold to globally sales will boom. If elderly are found to be vulnerable for example. At £20k per machine it’s not out of the range of many institutions buying just to reassure staff, students, residents etc. Then there are the sales to governments who are interested in testing cases in the community. Remember the ONS study at the moment is visiting over 100,000 households monthly paying each resident of that house £25 each for swab samples at a cost of well over £10m per month. So governments are still very interested in monitoring the virus in the community. I can envisage many uses for the machine. People also forget future products Kromek scientists can develop. Something which would be well priced into the share price on a Nasdaq listing
aqc888
Chat Pages: 220  219  218  217  216  215  214  213  212  211  210  209  Older
ADVFN Advertorial
Your Recent History
LSE
KMK
Kromek
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211020 11:21:59